CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Planned sale Chief Legal Officer sold 2,932 shares at $27.09 ($79,428)
- 4 Planned sale Chief Executive Officer sold 18,703 shares at $27.09 ($506,664)
- 4 Planned sale Chief Medical Officer sold 2,932 shares at $27.09 ($79,428)
- 4 Planned sale Chief Commercial Officer sold 2,932 shares at $27.09 ($79,428)
- 4 Planned sale Chief Financial Officer sold 2,932 shares at $27.09 ($79,428)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Director sold 200 shares at $43.84 ($8,768)
- 4 Planned sale Chief Medical Officer sold 2,454 shares at $43.78 ($107,436)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Medical Officer sold 200 shares at $43.81 ($8,762)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chief Medical Officer sold 3,302 shares at $43.92 ($145,024)
Page 5 of 66 · 1,304 filings